SRC and chronic myelogenous leukemia, BCR-ABL1 positive: Src is widely expressed in myriad cell types and functions as a key regulatory factor in cell signal transduction, playing a crucial role in pathological and physiological processes, such as cell development and tumor formation.[33, 34] Previous research on Src focused primarily on malignant tumors, including chronic myeloid leukemia and breast tumors.[25, 35] However, recently, its potential to regulate the immune system has been preliminarily explored, revealing that Src mediates multiple signaling pathways involved in inflammatory disease damage.[36, 37] Kao et al.